COVID-19 cytokine storm syndrome: a threshold concept

LYC Chen, TTT Quach - The Lancet Microbe, 2021 - thelancet.com
The COVID-19 pandemic has placed the practice of medicine at a threshold overlooking a
new and different era, 1 and has led to the evolving concept of COVID-19 cytokine storm …

[PDF][PDF] COVID-19: perspectives on the potential novel global threat

I Gentile, L Abenavoli - Rev Recent Clin Trials, 2020 - unicz.it
For long time human coronaviruses (HCoVs) have been deemed as nearly inconsequential
pathogens, responsible for up to 30% of common cold cases worldwide each year [1] and …

Role for anti-cytokine therapies in severe coronavirus disease 2019

LF Buckley, GF Wohlford, C Ting… - Critical care …, 2020 - journals.lww.com
Objectives: The causative agent for coronavirus disease 2019, severe acute respiratory
syndrome coronavirus 2, appears exceptional in its virulence and immunopathology. In …

Precision therapeutic targets for COVID-19

ZA Krumm, GM Lloyd, CP Francis, LH Nasif… - Virology journal, 2021 - Springer
Beginning in late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
emerged as a novel pathogen that causes coronavirus disease 2019 (COVID-19). SARS …

[HTML][HTML] Cytokine storm in novel coronavirus disease (COVID-19): expert management considerations

Y Mehta, SB Dixit, KG Zirpe… - Indian journal of critical …, 2020 - ncbi.nlm.nih.gov
Background Cytokine storm is caused by the colossal release of proinflammatory cytokines
[eg, IL (interleukin)-2, IL-6, IL-8 TNF (tumor necrosis factor)-α, etc.] causing dysregulated …

[HTML][HTML] COVID-19 pandemic: a new chapter in the history of infectious diseases

AA Balkhair - Oman medical journal, 2020 - ncbi.nlm.nih.gov
Abdullah A. Balkhair, et al. infected individual could infect three), and can spread through
asymptomatic or minimally symptomatic individuals. 12 It has a median incubation period of …

SARS-CoV-2: pathogenesis, and advancements in diagnostics and treatment

K Khalaf, N Papp, JTT Chou, D Hana… - Frontiers in …, 2020 - frontiersin.org
The emergence and rapid spread of SARS-CoV-2 in December 2019 has brought the world
to a standstill. While less pathogenic than the 2002–2003 SARS-CoV, this novel …

[HTML][HTML] Hazards of the cytokine storm and cytokine-targeted therapy in patients with COVID-19

M Quirch, J Lee, S Rehman - Journal of medical Internet research, 2020 - jmir.org
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
challenged medicine and health care on a global scale. Its impact and frightening mortality …

Novel coronavirus 2019 (COVID-19): a case report and review of treatments

S Douedi, J Miskoff - Medicine, 2020 - journals.lww.com
Interventions: She was being treated aggressively in the intensive care unit with high dose
intravenous ascorbic acid, hydroxychloroquine, and anti-interleukin-6 monoclonal antibody …

Treating COVID-19: are we missing out the window of opportunity?

J Sundararaj Stanleyraj, N Sethuraman… - Journal of …, 2021 - academic.oup.com
Severe COVID-19 is a biphasic illness, with an initial viral replication phase, followed by a
cascade of inflammatory events. Progression to severe disease is predominantly a function …